Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.325
-0.015 (-1.12%)
Apr 29, 2026, 1:39 PM CET

STO:NEWBRY Balance Sheet

Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Feb '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Cash & Equivalents
10.0714.5615.38.5333.3313.15
Cash & Short-Term Investments
10.0714.5615.38.5333.3313.15
Cash Growth
-21.68%-4.84%79.44%-74.42%153.59%-
Accounts Receivable
-7.0615.249.1201.08
Other Receivables
26.2914.177.016.390.791.25
Receivables
26.2921.2322.2515.510.792.33
Inventory
10.87952.111.77-
Prepaid Expenses
-1.671.421.090.580.29
Total Current Assets
47.2346.4643.9727.2436.4715.77
Goodwill
-0.341.262.133.043.95
Other Intangible Assets
30.0330.5545.6443.5547.3923.09
Total Assets
77.2677.3590.8772.9286.9142.81
Accounts Payable
-7.321.944.282.041.88
Accrued Expenses
-4.466.283.190.892.23
Current Income Taxes Payable
-0.350.080.160.180.07
Current Unearned Revenue
---1.63--
Other Current Liabilities
42.3518.7221.142.522.960.16
Total Current Liabilities
42.3530.8529.4511.776.064.34
Other Long-Term Liabilities
3.613.759.5111.7712.08-
Total Liabilities
45.9634.638.9523.5418.144.34
Common Stock
31.30.970.770.620.620.16
Additional Paid-In Capital
-121.9106.7288.7188.7143.89
Comprehensive Income & Other
--80.12-55.58-39.96-20.57-5.58
Shareholders' Equity
31.342.7551.9249.3868.7738.47
Total Liabilities & Equity
77.2677.3590.8772.9286.9142.81
Net Cash (Debt)
10.0714.5615.38.5333.3313.15
Net Cash Growth
-21.68%-4.84%79.44%-74.42%153.59%-
Net Cash Per Share
0.350.560.710.441.87-
Filing Date Shares Outstanding
30.430.424.2619.5219.5215.68
Total Common Shares Outstanding
30.430.424.2619.5219.5215.68
Working Capital
4.8815.6114.5315.4730.4211.43
Book Value Per Share
1.031.412.142.533.522.45
Tangible Book Value
1.2611.875.023.718.3411.43
Tangible Book Value Per Share
0.040.390.210.190.940.73
Source: S&P Capital IQ. Standard template. Financial Sources.